One journey. One legacy. One mission. One movement

We are a team of many, with the focus of one – pushing the frontiers of cancer research, treatment and prevention.

Twenty years in the making

As we stand together reflecting on our rich history, we embrace the cause that unites us.

1999

Alvin and Ruth Siteman’s gift of $35 million establishes the Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.

2001

The 14-story Center for Advanced Medicine opens. The building consolidates the cancer-related outpatient services of WUSM and Barnes-Jewish Hospital and houses the Alvin J. Siteman Cancer Center.

2004

Siteman Cancer Center is awarded the prestigious Comprehensive Cancer Center designation from the NCI, placing Siteman among the most highly ranked cancer institutions in the nation. Learn more about our NCI designation.

2006

Siteman Cancer Center is selected to join the National Comprehensive Cancer Network (NCCN), an alliance of the world’s premier cancer centers, charged with setting the standard for cancer care.

2008

Timothy J. Ley, MD; Elaine Mardis, PhD; and Richard Wilson, PhD, working in conjunction with many colleagues at The Genome Center and Siteman Cancer Center, sequence the first human cancer genome from a patient with acute myeloid leukemia (AML), as published in Nature.

2008

The Institute for Public Health at Washington University is established through a partnership of Siteman Cancer Center, Washington University School of Medicine and the George Warren Brown School of Social Work.

2011

Siteman Cancer Center performs its 5,000th bone marrow transplant, placing it among the top five cancer centers in the United States.

2013

The Kling Center for Proton Therapy, the first single-vault proton therapy center in the country, opens at Siteman Cancer Center’s main campus.

2014

The world’s first MRI-guided radiation therapy treatment is performed at Siteman Cancer Center. The treatment technique allows tumors to be visualized and treatment adapted.

2015

The NCI awards Siteman an “exceptional” rating, based on a rigorous review of Siteman’s research programs. The rating, which accompanies Siteman’s re-certification as a Comprehensive Cancer Center, is the highest possible by the NCI.

2016

Siteman and St. Louis Children’s Hospital establish “Siteman Kids at St. Louis Children’s Hospital,” a partnership focused on caring for children and adolescents with cancer.

2017

Siteman becomes one of the first cancer centers nationwide to offer the newly approved CAR-T cell therapy called Yescarta. CAR-T cell therapy involves extracting a patient’s own T cells and supercharging them to home in on cancer cells and destroy them.

2018

The NCI awards Washington University researchers and physicians a second $11.3 million, five-year Specialized Program of Research Excellence (SPORE) grant to further high-level investigations into leukemia and related blood cancers.